Associations between reduced GR expression and unfavorable tumor features have also been described for adrenocortical carcinomas [50], thymic epithelial tumors [62], ductal adenocarcinoma of the pancreas [42], cervical cancer [56], colorectal adenocarcinomas, and non-small cell lung cancer [45]. This evidence concerns the gene NR3C1 and cervical cancer.